NL9102009A - Produktie van bioactieve peptiden met recombinante cellen. - Google Patents

Produktie van bioactieve peptiden met recombinante cellen. Download PDF

Info

Publication number
NL9102009A
NL9102009A NL9102009A NL9102009A NL9102009A NL 9102009 A NL9102009 A NL 9102009A NL 9102009 A NL9102009 A NL 9102009A NL 9102009 A NL9102009 A NL 9102009A NL 9102009 A NL9102009 A NL 9102009A
Authority
NL
Netherlands
Prior art keywords
cells
protein
proteins
bioactive peptide
precursor
Prior art date
Application number
NL9102009A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Katholieke Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Univ filed Critical Stichting Katholieke Univ
Priority to NL9102009A priority Critical patent/NL9102009A/nl
Priority to HU9401604A priority patent/HUT67739A/hu
Priority to US08/244,492 priority patent/US5708140A/en
Priority to AT92923809T priority patent/ATE174629T1/de
Priority to CA002123567A priority patent/CA2123567A1/en
Priority to DE69227921T priority patent/DE69227921D1/de
Priority to FI942442A priority patent/FI942442A7/fi
Priority to JP5509807A priority patent/JPH07501448A/ja
Priority to AU29461/92A priority patent/AU675919B2/en
Priority to PCT/EP1992/002740 priority patent/WO1993011248A1/en
Priority to EP92923809A priority patent/EP0614490B1/de
Publication of NL9102009A publication Critical patent/NL9102009A/nl
Priority to NO941982A priority patent/NO941982L/no
Priority to US08/709,915 priority patent/US5804417A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NL9102009A 1991-11-29 1991-11-29 Produktie van bioactieve peptiden met recombinante cellen. NL9102009A (nl)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NL9102009A NL9102009A (nl) 1991-11-29 1991-11-29 Produktie van bioactieve peptiden met recombinante cellen.
DE69227921T DE69227921D1 (de) 1991-11-29 1992-11-27 Herstellung von Proteinen mittels Protein 7B2
US08/244,492 US5708140A (en) 1991-11-29 1992-11-27 Production of proteins using 7B2 protein
AT92923809T ATE174629T1 (de) 1991-11-29 1992-11-27 Herstellung von proteinen mittels protein 7b2
CA002123567A CA2123567A1 (en) 1991-11-29 1992-11-27 Production of proteins using 7b2 protein
HU9401604A HUT67739A (en) 1991-11-29 1992-11-27 Production of proteins using fb2 protein
FI942442A FI942442A7 (fi) 1991-11-29 1992-11-27 Proteiinien tuotto 7B2-proteiinia käyttäen
JP5509807A JPH07501448A (ja) 1991-11-29 1992-11-27 ７ｂ２タンパク質を利用するタンパク質の生産
AU29461/92A AU675919B2 (en) 1991-11-29 1992-11-27 Production of proteins using 7B2 protein
PCT/EP1992/002740 WO1993011248A1 (en) 1991-11-29 1992-11-27 Production of proteins using 7b2 protein
EP92923809A EP0614490B1 (de) 1991-11-29 1992-11-27 Herstellung von Proteinen mittels Protein 7B2
NO941982A NO941982L (no) 1991-11-29 1994-05-27 Fremstilling av proteiner ved anvendelse av 7B2 protein
US08/709,915 US5804417A (en) 1991-11-29 1996-09-09 Recombinant production of proteins using 7B2 protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9102009A NL9102009A (nl) 1991-11-29 1991-11-29 Produktie van bioactieve peptiden met recombinante cellen.
NL9102009 1991-11-29

Publications (1)

Publication Number Publication Date
NL9102009A true NL9102009A (nl) 1993-06-16

Family

ID=19859984

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9102009A NL9102009A (nl) 1991-11-29 1991-11-29 Produktie van bioactieve peptiden met recombinante cellen.

Country Status (11)

Country Link
US (2) US5708140A (de)
EP (1) EP0614490B1 (de)
JP (1) JPH07501448A (de)
AT (1) ATE174629T1 (de)
AU (1) AU675919B2 (de)
CA (1) CA2123567A1 (de)
DE (1) DE69227921D1 (de)
FI (1) FI942442A7 (de)
HU (1) HUT67739A (de)
NL (1) NL9102009A (de)
WO (1) WO1993011248A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025681A1 (en) * 1992-06-11 1993-12-23 New York University A cytoplasmic chaperonin and methods of making and using it
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H
DE69329202T2 (de) * 1992-10-02 2001-03-29 Research Corp. Technologies, Inc. Methoden der erhöhung der sekretion von überexpremierten proteinen
GB9223816D0 (en) 1992-11-13 1993-01-06 Medical Res Council Heat shock proteins and the treatment of tumours
US5688651A (en) * 1994-12-16 1997-11-18 Ramot University Authority For Applied Research And Development Ltd. Prevention of protein aggregation
JPH09173078A (ja) * 1995-09-14 1997-07-08 Tadayuki Imanaka 分子シャペロンを用いる蛋白質の製造方法
JP2000508178A (ja) * 1996-05-14 2000-07-04 スミスクライン・ビーチャム・コーポレイション 新規化合物
AU5602100A (en) * 1999-06-09 2000-12-28 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
CA2414775A1 (en) * 2000-05-03 2001-11-08 Expressive Constructs, Inc. A method and device for improving protein stability and solubility
JP4528460B2 (ja) * 2000-06-30 2010-08-18 株式会社東芝 半導体素子
US20040138116A1 (en) * 2002-08-30 2004-07-15 Vincent Geenen Tolerogenic approach for type 1 diabetes
EP1624886A2 (de) * 2003-05-12 2006-02-15 Expressive Constructs, Inc. Verfahren zur erhöhung der zell- und gewebevariabilität
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
FR3008713B1 (fr) * 2013-07-18 2016-11-25 Commissariat Energie Atomique Procede d'extraction et de purification d'acides nucleiques et tampons mis en œuvre

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8702590A (nl) * 1987-10-30 1989-05-16 Stichting Katholieke Univ Eiwit 7b2 alsmede recombinant dna en cdna, mrna, en antilichamen voor 7b2 en werkwijze voor het detecteren van 7b2.
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells

Also Published As

Publication number Publication date
HU9401604D0 (en) 1994-09-28
US5804417A (en) 1998-09-08
FI942442L (fi) 1994-07-25
JPH07501448A (ja) 1995-02-16
WO1993011248A1 (en) 1993-06-10
AU675919B2 (en) 1997-02-27
US5708140A (en) 1998-01-13
ATE174629T1 (de) 1999-01-15
CA2123567A1 (en) 1993-06-10
HUT67739A (en) 1995-04-28
AU2946192A (en) 1993-06-28
FI942442A0 (fi) 1994-05-25
FI942442A7 (fi) 1994-07-25
EP0614490B1 (de) 1998-12-16
DE69227921D1 (de) 1999-01-28
EP0614490A1 (de) 1994-09-14

Similar Documents

Publication Publication Date Title
Natori et al. Chromogranin B (secretogranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor.
US7893208B2 (en) Muteins of human tear lipocalin
ES2375330T3 (es) Expresión directa de péptidos en medios de cultivo.
CA2243718A1 (en) Diabetes therapy
Joly et al. Subunit dynamics in Escherichia coli preprotein translocase.
CN108165593A (zh) 胶原蛋白7及相关方法
JPH09504166A (ja) リーダー配列なしに細胞質外に輸送される融合ポリペプチドの発現
CN106434717A (zh) 一种生物合成制备人glp‑1多肽或其类似物的方法
Burns et al. Calreticulin: from Ca2+ binding to control of gene expression
KR102138272B1 (ko) BiP 단편을 포함하는 재조합 벡터 및 상기 벡터를 이용한 재조합 단백질의 제조 방법
US5700660A (en) Positional control of selenium insertion in polypeptides for X-ray crystallography
CN112313336A (zh) 一种用于优化抗体表达的方法
US5708140A (en) Production of proteins using 7B2 protein
JP7646224B2 (ja) タンパク質発現のためのシステムおよび方法
Lennarz Studies on oligosaccharyl transferase in yeast
Murakami et al. Signal sequence region of mitochondrial precursor proteins binds to mitochondrial import receptor.
KR19990011970A (ko) 포스포리불로키나제를 융합파트너로 이용하는 재조합 인간 부갑상선호르몬의 발현벡터
JP2549504B2 (ja) Ｄｎａ塩基配列、ポリペプチド分泌発現ベクター及び形質転換微生物
Buu et al. The yeast RNA-binding protein Rbp1p modifies the stability of mitochondrial porin mRNA
CN113981027A (zh) 制备治疗性蛋白质的方法
CN114057889A (zh) 二硫键稳定的IL15-IL15Rα复合物及其应用
Rogers et al. Purification, crystallization and preliminary crystallographic studies of the ligand-binding domain of a plant vacuolar sorting receptor
US7189808B2 (en) Transfer compounds, production and use thereof
Manoharan et al. High-level production and purification of biologically active proteins from bacterial and mammalian cells using the tandem pGFLEX expression system
HK40068105A (en) Methods of manufacturing therapeutic proteins

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed